Anbio Biotechnology vs Beyond Air
Anbio Biotechnology and Beyond Air are similar in size: $8.6m and $7.7m of revenue in their latest fiscal years. Beyond Air grew faster (107.3% against 5.6%). Anbio Biotechnology kept more of each dollar of sales as profit: a net margin of 74.1% against -433.0%.
| Latest fiscal year | Anbio BiotechnologyNNNN, 2025 | Beyond AirXAIR, 2026 |
|---|---|---|
| Revenue | $8.6m | $7.7m |
| Revenue growth | 5.6% | 107.3% |
| Net income | $6.4m | −$33.2m |
| Operating margin | 66.7% | — |
| Net margin | 74.1% | -433.0% |
| Return on equity | 27.0% | — |
| Free cash flow | — | −$19.2m |
| Cash | $7.8m | $6.7m |
| Total debt | $0 | $21.6m |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | 54 |
| Market value | $158m | $1.7m |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 0 buys, 0 sales | 6 buys, 0 sales |